KIMS LTD IPO is all set to make a debut in the stock market with an issue size of 2143.74 Cr. Krishna Institute of Medical Sciences Limited is one of the largest healthcare groups in AP and Telangana. KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, & tertiary care in tier 2-3 cities.
KIMS LTD IPO -Overview
| Krishna Institute of Medical Sciences Limited IPO Issue Date | 16-18 June 2021 |
| Krishna Institute of Medical Sciences Limited IPO Opening Date | 16 July 2021 |
| Krishna Institute of Medical Sciences Limited IPO Face Value | INR 10 per share |
| Krishna Institute of Medical Sciences Limited IPO Price | INR 825 per share |
| Krishna Institute of Medical Sciences Limited IPO Lot Size | 18 Shares |
| Issue Size | 2,143.74 Cr |
| Offer for sale | 200 Cr |
| Issue Type | Book built Issue IPO |
| Listing At | BSE, NSE |
| QIB Shares Offered | 5.26 times |
| NII (HNI) Shares | 1.89 times |
| Company Promoters | Dr. Bhaskara Rao Bollineni, Rajyasri Bollineni, Dr. Abhinay Bollineni, Adwik Bollineni, and Bollineni Ramanaiah Memorial Hospitals Private Limited are the company promoters. |
KIMS LTD IPO-Tentative Dates
| Krishna Institute of Medical Sciences Limited IPO opening date | 16 June 2021 |
| Krishna Institute of Medical Sciences Limited IPO closing date | 18 June 2021 |
| Basis of Allotment | 23 June 2021 |
| Initiation of Refunds | 24 June 2021 |
| The credit of Shares to Demat | 25 June 2021 |
| Krishna Institute of Medical Sciences Limited IPO Listing Date | 28 June 2021 |
KIMS LTD IPO – Industry Overview.
The Indian Healthcare delivery market is estimated at ₹ 4.3 trillion in fiscal 2021CRISILResearch estimates the Indian healthcare delivery market at ₹ 4.3 trillion in value terms and 1.7 billion treatments in volume terms (inclusive of both in-patient and out-patient) in fiscal 2021, with the growth being contributed by the increased government expenditure onto the sector to combat Covid-19 as private hospitals are expected to witness a decline in revenues. In value terms, the IPD is expected to account for nearly 69%, while OPD is likely to account for the remaining. Though in terms of volumes, OPD is estimated to outweigh IPD volumes, with the latter contributing the bulk of the revenues to healthcare facilities. The share of IPD (in value terms) is expected to grow from 69% in the current fiscal year to nearly 74% in fiscal 2024.
KIMS LTD IPO – Company Overview
Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in AP and Telangana in terms of several patients treated and treatments offered, according to the CRISIL Report. KIMS provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in Tier 1 cities. KIMS operate 9 multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of December 31, 2020, which is 2.2 times more beds than the second largest provider in AP and Telangana, according to the CRISIL report. KIMS offer a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, organ transplantation, renal sciences, and mother & childcare.
KIMS LTD IPO -Objectives
- To make repayment/prepayment of borrowings available by the firm and subsidiaries i.e. KHKPL, SIMSPL, and KHEPL.
- To meet general corporate purposes.
KIMS LTD IPO – Financial Statements
| Particulars | 31-Mar21 | 31-Mar-20 | 31-Mar-19 |
| Total Assets | 14,361.54 | 11,958.90 | 11,197.13 |
| Total Revenue | 13,401.02 | 11,287.28 | 9,238.69 |
| Profit After Tax | 2,054.79 | 1,150.72 | 488.07 |
KIMS LTD IPO – Strengths
- One of the largest corporate healthcare service providers in AP and Telangana.
- Highly qualified and trained doctors and medical support staff.
- Strong operational and financial performance.
- Experienced managerial team.
KIMS LTD IPO- Weakness
- Dependency on its health care professionals, including doctors, that KIMS engages on a consultancy basis.
- Inability to comply with applicable safety, health, environmental and other governmental regulations.
- Risk of legal claims and regulatory actions arising out of the medical services provided by KIMS.
Company Contact Information
Krishna Institute of Medical Sciences Limited
D. No. 1-8-31/1, Minister’s Road,
Secunderabad – 3, 500 003
Phone: +91 40 4418 6000
Email: cs@kimshospitals.com
Website: http://www.kimshospitals.com/
KIMS IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: kims.ipo@linkintime.com
Website: https://linkintime.co.in/
KIMS IPO Lead Manager(s)
- Axis Capital Limited (Past IPO Performance)
- Credit Suisse Securities (India) Private Limited (Past IPO Performance)
- IIFL Securities Ltd (Past IPO Performance)
- Kotak Mahindra Capital Company Limited (Past IPO Performance)
